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Introduction: Simvastatin is a semisynthesis statin. Statins inhibit 3-hydroxy-3-
methylglutaryl coenzyme A reductase, a key enzyme of cholesterol synthesis, in 
AMPK (AMP-activated protein kinase) signaling pathway. Simvastatin is able to 
cross blood brain barrier more than the other statins, due to its lipophilic nature. 
There is controversy about the effect of simvastatin on Alzheimer’s disease (AD). 
For example, simvastatin can induce AD through insulin signaling pathway but can 
ameliorate AD via MAPK (Mitogen-Activated Protein Kinase) signaling pathway.  
In this study, we report the synthesis of a conjugated form of simvastatin with 
citicoline, to block negative effect of simvastatin on insulin signaling pathway and 
increase positive effect of simvastatin on MAPK signaling pathway and chitosan as 
a linker between these two drugs.   
Methods and Results: for simvastatin-n-succinyl chitosan-citicoline synthesis, 
chitosan reacted with succinic acid to form n-succinyl chitosan. Then simvastatin 
connected to n-succinyl chitosan via acetylation reaction. After 24 hours citicoline 
was added to reaction media. H-NMR and FT-IR were done to examine whether the 
conjugation reaction has been done or not. Characterization and morphology tests 
have been done on reaction result.  
H-NMR results approved the synthesis of drug-polymer. FT-IR results showed both 
amide and ester peaks.  Maximum absorptions (λmax) of all primary chemicals were 
seen in UV visible spectroscopy results of conjugated form. SEM result showed that 
the conjugated form has nanoparticulate structure in size range of 100-300 
nanometers. X-RD result showed a peak under 25 theta. Another characterization 
test was RBC hemolysis with six different concentrations, in which normal saline 
was negative control and Triton was positive control.  
Conclusions: Conjugation of lipophilic simvastatin with hydrophilic citicoline to 
improve AD can be done with helping of a polymer which is rich in carboxylic acid.  
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